A new study from Yale School of Medicine has shown promise in developing a novel cancer treatment using gene editing to simultaneously target multiple immune suppression genes within the tumor microenvironment. This approach has the potential to benefit more patients than current therapies.
The tissue adjacent to a tumor behaves differently than areas farther away; the tumor's cancerous cells influence their surroundings, blocking the body's immune defenses and creating a sort of haven in which the tumor can grow. Treatments that target some of these pro-tumor actions are effective in a number of cancers, but only for some patients; in others, these treatments have little effect.
Yale researchers have developed a new approach that simultaneously targets several of these pro-tumor actions at once, which they have demonstrated can effectively reduce tumor growth across several types of cancers. Traditional therapies target one molecule in the tumor microenvironment, but the microenvironment is so complex, targeting one thing doesn't always work, said Sidi Chen, an associate professor of genetics and neurosurgery at Yale School of Medicine and senior author of the study. For example, the most well-known of these immunotherapies only benefits 20 to 30% of patients. When these therapies don't work, it can be because the molecule they're targeting doesn't play a major role in the individual's tumor or because there is some other molecule that has a similar effect and compensates for the loss of the one targeted by the treatment. Or it can be even more complex with say a large network of pathways within the tumor microenvironment all working to suppress the body's immune response, said Chen, who is also a researcher with the Systems Biology Institute at Yale's West Campus. So how do you hit multiple targets in the same go?For their approach, Chen and his colleagues used a gene editing molecule called Cas13, which targets and degrades RNA. (Its more widely discussed counterpart, known as Cas9, targets DNA.) One benefit of Cas13 is its ability to target multiple genes with one molecular package. So the researchers identified several genes that can suppress immune responses and developed a Cas13 system that targeted each of them. When they delivered the Cas13 package into tumor microenvironments in mice, they found that it silenced those immune suppression genes (essentially un-silencing or re-activating the immune system), remodeled the microenvironment, and boosted antitumor immune responses. The result was reduced tumor growth across four types of cancers: breast cancer, melanoma, pancreatic cancer, and colon cancer. While more research will be required to further optimize this approach for efficacy and safety, researchers say this technology holds promise as both an'off-the-shelf' treatment for more general use and one that can be tailored for specific individuals by swapping gene targets as necessary. The researchers are continuing this line of research with the goal of working toward translation and clinical trials
Cancer Treatment Gene Editing Cas13 Immune Suppression Tumor Microenvironment Immunotherapy
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Cornell Researchers Develop Miniature VR Headsets to Study Mouse Brain ActivityResearchers from Cornell University have created MouseGoggles, miniature VR headsets designed to immerse mice in virtual environments. These headsets, built with affordable components, aim to provide deeper insights into the neural activity related to spatial navigation and memory function in mice. The technology holds potential for understanding disorders like Alzheimer's disease and exploring potential treatments.
Read more »
The Secrets of Hibernation: Yale Researchers Explore Sleep's Deepest DepthsYale graduate students are investigating the mysteries of hibernation, studying everything from involuntary movements during torpor to the surprising process of sexual maturation in a state of deep metabolic depression.
Read more »
Engineering researchers develop deep-UV microLED display chips for maskless photolithographyIn a breakthrough set to revolutionize the semiconductor industry, engineers have developed the world's first-of-its-kind deep-ultraviolet (UVC) microLED display array for lithography machines.
Read more »
South Korean Researchers Develop Self-Extinguishing, Explosion-Proof Solid-State BatteryDGIST researchers have created a groundbreaking solid polymer electrolyte battery with enhanced safety features and longer lifespan.
Read more »
Aalto University Researchers Develop a More Efficient and Environmentally Friendly Infrared PhotodiodeA team of researchers at Aalto University in Finland has developed a new type of infrared photodiode that is 35 percent more sensitive than other currently used germanium-based applications. This breakthrough offers a more sustainable and efficient alternative to the commonly used InGaAs material, which is toxic and not CMOS compatible.
Read more »
Chinese Researchers Develop Perovskite Solar Cells with Enhanced Efficiency and StabilityChinese scientists have made a breakthrough in perovskite solar cell technology by developing a new type of cell that boasts higher efficiency and improved stability. The key innovation lies in the use of a hole-selective interlayer that effectively inhibits ion diffusion, a major cause of instability in traditional perovskite solar cells.
Read more »